GlobalData on MSN

uBriGene and Cellinfinity BIO collaborate to accelerate in vivo CAR-T therapies

The collaboration leverages uBriGene’s LVV Turbo platform for GMP lentiviral vector manufacturing and regulatory support.
Morningstar

uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its ...

"Our LVV Turbo™ platform resolves the core bottlenecks in LVV manufacturing-boosting productivity, increasing yield, and lowering cost-powered by our disruptive closed downstream system that ...
WLNS.com

uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its ...

GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...